Teva Lowers Forecast As Q3 Revenues Decline Amid Growing Generic Competition

But Opioid Crisis Settlement On Track

A sad piggy bank behind stack of euro coins symbolizing the fall of monetary assets.
Teva's Profits Have Dipped Despite Lower R&D Spend • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip